2 Patents
- US124199542025Targeted Chimeric Antigen Receptor Modified T Cells for Treatment of Il13rα2 Positive Malignancies
The Board Of Trustees Of The Leland Stanford Junior University
0 cites - 0 cites
The Board Of Trustees Of The Leland Stanford Junior University